These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31577763)

  • 1. Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections: A Bayesian network meta-analysis of randomized clinical trials.
    Chen L; Liang X; Jiang J; Li X; Li Y
    Medicine (Baltimore); 2019 Oct; 98(40):e17436. PubMed ID: 31577763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenems vs alternative antibiotics for the treatment of complicated urinary tract infection: A systematic review and network meta-analysis.
    Tan X; Pan Q; Mo C; Li X; Liang X; Li Y; Lan Y; Chen L
    Medicine (Baltimore); 2020 Jan; 99(2):e18769. PubMed ID: 31914101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis.
    Kong W; Deng T; Li S; Shu Y; Wu Y
    BMC Infect Dis; 2023 Apr; 23(1):256. PubMed ID: 37085768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.
    Brink AJ; Botha RF; Poswa X; Senekal M; Badal RE; Grolman DC; Richards GA; Feldman C; Boffard KD; Veller M; Joubert I; Pretorius J
    Surg Infect (Larchmt); 2012 Feb; 13(1):43-9. PubMed ID: 22220506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial comparing the efficacy of tigecycline versus meropenem in the treatment of postoperative complicated intra-abdominal infections.
    Wang HJ; Xing XZ; Qu SN; Huang CL; Zhang H; Wang H; Yang QH; Yuan ZN
    Ann Palliat Med; 2021 Feb; 10(2):1262-1275. PubMed ID: 33040562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of eravacycline: A meta-analysis.
    Eljaaly K; Ortwine JK; Shaikhomer M; Almangour TA; Bassetti M
    J Glob Antimicrob Resist; 2021 Mar; 24():424-428. PubMed ID: 33621690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials.
    Chen TY; Hsu CK; Shih SC; Weng TS; Tang HJ; Lai CC
    Int J Antimicrob Agents; 2023 Aug; 62(2):106844. PubMed ID: 37160243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenems vs β-Lactam Monotherapy or Combination Therapy for the Treatment of Complicated Intra-abdominal Infections: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Li Y; Chen L; Jiang J; Li X; Huang T; Liang X
    Open Forum Infect Dis; 2019 Oct; 6(10):ofz394. PubMed ID: 31660356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of eravacycline compared with current clinically common antibiotics in the treatment of adults with complicated intra-abdominal infections: A Bayesian network meta-analysis.
    Meng R; Guan X; Sun L; Fei Z; Li Y; Luo M; Ma A; Li H
    Front Med (Lausanne); 2022; 9():935343. PubMed ID: 36186801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study.
    Chen F; Shen C; Pang X; Zhang Z; Deng Y; Han L; Chen X; Zhang J; Xia Q; Qian Y
    Transpl Infect Dis; 2020 Feb; 22(1):e13199. PubMed ID: 31627248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenems versus alternative β-lactams monotherapy or in combination for febrile neutropenia: Systematic review and meta-analysis of randomized controlled trial.
    Tang X; Chen L; Li Y; Jiang J; Li X; Liang X
    Medicine (Baltimore); 2020 Oct; 99(43):e22725. PubMed ID: 33120768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of non-polymyxin antibiotics against nosocomial pneumonia, complicated intra-abdominal infection, or complicated urinary tract infection: A network meta-analysis of randomised clinical trials.
    Lin MH; Shen YC; Cheng HY; Teng CK; Chen WC; Lin YC; Hung CC
    J Glob Antimicrob Resist; 2023 Sep; 34():46-58. PubMed ID: 37328062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
    Cai Y; Wang R; Liang B; Bai N; Liu Y
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1162-72. PubMed ID: 21173186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ceftazidime-avibactam in the treatment of complicated intra-abdominal infections (CIAIs) and complicated urinary tract infections (CUTIs): A meta-analysis of randomized controlled trials.
    Zhang Y; Tao LN; Qu XY; Niu JQ; Ding YH; Zhang SX
    Rev Assoc Med Bras (1992); 2018 Mar; 64(3):253-263. PubMed ID: 29641778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison.
    Edwards SJ; Clarke MJ; Wordsworth S; Welton NJ
    Curr Med Res Opin; 2009 Jan; 25(1):251-61. PubMed ID: 19210156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital.
    Avkan-Oguz V; Yapar N; Alp-Cavus S; Demir Onder K; Aktas E; Gulay Z; Cakır N
    Int J Clin Pract; 2013 Jun; 67(6):505-11. PubMed ID: 23679904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of relebactam/imipenem/cilastatin in Japanese patients with complicated intra-abdominal infection or complicated urinary tract infection: A multicenter, open-label, noncomparative phase 3 study.
    Kohno S; Bando H; Yoneyama F; Kikukawa H; Kawahara K; Shirakawa M; Aoyama N; Brown M; Paschke A; Takase A
    J Infect Chemother; 2021 Feb; 27(2):262-270. PubMed ID: 33191112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.